

business report with magnifying glass | Photo Credit: bluebay2014
4 Results Today, May 20, 2026, Live Updates: Find all the latest Q4 results 2026 updates of Action Construction Equipment, AGI Infra, AK Capital Services, Alna Trading & Exports, Amagi Media Labs, Whirlpool of India, Xpro India, Yash Management & Satellite, and Welcast Steels.
BEL, BPCL, Bosch, Mankind Pharma, Hatsun Agro, RITES, Zydus Lifesciences, and more in focus
Stay tuned for more from business line
- May 20, 2026 09:18
Stock market live, Q4 results live: Sensex, Nifty drag
Sensex dragged 625.08 pts or 0.83% to 74,575.77 at 9.16 am after opening at 74,806.49 from the previous close of 75,200.85, and Nifty 50 fell 169.05 pts or 0.72% to 23,448.95.
- May 20, 2026 09:13
Safari Industries Q4 results live:
MNCL research Safari Industries Q4FY26 First Cut | Beat across
CMP- Rs 1,427, Target price1,860 (UR)- Mcap- Rs 69.8bn
Revenue- Safari Industries reported YoY revenue growth of 12.4% to Rs.4,733 mn (-7.6% QoQ), (MNCL Est- Rs 4,569 mn).
Margins- Gross margins for the quarter stood at 49.3%, up 11bps YoY (+283bps QoQ), however OPM contracted by 139bps YoY to 13.1% (+220bps QoQ) (MNCL Est- 9.3%), largely on account of increase in other expenses (+90bps YoY) and employee cost (+60bps YoY).
EBITDA- The company reported an EBITDA of Rs 618mn up 1.6% YoY (MNCL Est- Rs 423mn) increase in OPEX cost impacted overall EBITDA.
PAT The Company reported a PAT of Rs 375mn, flat YoY (MNCL estimates- Rs 220mn)
Management Update – The company’s CFO, Mr. Vineet Poddar, has tendered his resignation, with his last working day being 30th June 2026.
View:- The company reported better-than-expected numbers, despite the current scenario largely led by strong volume growth. We will revisit our numbers soon
- May 20, 2026 09:12
Mankind Pharma Q4 RESULTS LIVE:
Mankind Pharma Q4 FY26 RESULTS
*Cons. Net Profit at ₹554.35 Cr vs ₹425.11 Cr ↑ 30.40% YoY, ↑ 35.60% QoQ
* Revenue at ₹3,442.93 Cr vs ₹3,079.17 Cr ↑ 11.81% YoY, ↓ 3.49% QoQ
* EBITDA at ₹929.88 Cr vs ₹683.18 Cr ↑ 36.11% YoY, ↑ 1.14% QoQ
* EBITDA Margins at 27.01% vs 22.19% YoY and 25.77% QoQ
- May 20, 2026 09:12
Mankind Pharma Q4 revenue rises 12%; chronic therapies drive margin expansion
- May 20, 2026 09:11
Kirloskar Industries Q4 results live:
Kirloskar Industries Ltd (KIL) (BSE: 500243; NSE: KIRLOSIND), announced today its financial results for the fourth quarter and the financial year ending March 31, 2026.
Commenting on the Q4 and FY 26 results, George Verghese, Managing Director, KIL, said “We reported a stable Q4 results for KIL. Looking at the full year consolidated numbers, we closed the financial year with Total Income of Rs. 7,013 crore i.e. 5% growth year on year and Net profit of Rs. 354 crore, 15% growth year on year.
Our material subsidiary, Kirloskar Ferrous Industries Limited, continued to deliver a resilient performance during the year, supported by operational stability, capacity optimization, and a strong focus on sustainable and profitable growth. The company’s continued emphasis on operational excellence, cost competitiveness, and responsible manufacturing has further strengthened its market position.
- May 20, 2026 09:11
Tamilnadu Petroproducts Q4 results live:
Tamilnadu Petroproducts Limited (TPL) reported its audited consolidated financial results for the quarter and financial year ended March 31, 2026, registering a healthy improvement in annual profitability during FY26.
On a consolidated basis, the company reported a profit after tax (PAT) of ₹97.45 crore for FY26, reflecting a growth of 67% compared with the ₹58.35 crore reported in the previous financial year. Consolidated profit before tax (PBT) increased to ₹128.75 crore from ₹78.57 crore in FY25.
Consolidated revenue from operations for FY26 stood at ₹1,464.06 crore as against ₹1,823.27 crore in the previous financial year. The company also reported total comprehensive income of ₹116.60 crore for FY26 compared with ₹63.21 crore in FY25.
For the quarter ended March 31, 2026, consolidated PAT stood at ₹8.09 crore compared with ₹26.88 crore in the corresponding quarter of the previous year. Consolidated PBT for the quarter was ₹10.06 crore against ₹35.98 crore in Q4 FY25. Revenue from operations during the quarter stood at ₹124.22 crore as compared with ₹454.29 crore in the year-ago quarter.
- May 20, 2026 09:10
Jai Bharat Maruti: Q4 SL Net Profit Rs. 78.90 Cr vs 19.60 Cr (YoY), Q4 Revenue Rs. 770 Cr vs 610 Cr (YoY), Q4 EBITDA margin 11.87% vs 9.45% (YoY) (Positive)
- May 20, 2026 09:10
ASK Auto: Q4 Net Profit Rs 71.5 Cr vs Rs 57.6 Cr (YoY), Q4 Revenue Rs 1147 Cr vs Rs 850 Cr (YoY) (Positive)
- May 20, 2026 09:10
Nephrocare: Q4 Net Profit Rs 30.4 Cr vs Rs 24.9 Cr (YoY), Q4 Revenue Rs 266 Cr vs Rs 219 Cr (YoY) (Positive)
- May 20, 2026 09:10
GPIL: Q4 Net Profit Rs 280 Cr vs 221 Cr (YoY), Q4 Revenue Rs 1610 Cr vs 1468 Cr (YoY) (Positive)
- May 20, 2026 09:10
Mankind: Q4 Cons Net Profit Rs. 554 Cr vs 423 Cr (YoY), Q4 Revenue Rs. 3443 Cr vs 3079 Cr (YoY) (Positive)
- May 20, 2026 09:09
Viyash: Q4 Net Profit Rs 52 Cr vs loss 26.2 Cr (YoY), Q4 Revenue Rs 920 Cr vs 772 Cr (YoY) (Positive)
- May 20, 2026 09:09
PNC Infratech: Q4 Cons Net Profit Rs. 108 Cr vs 75.50 Cr (YoY), Q4 Revenue Rs. 1617 Cr vs 1700 Cr (YoY), Q4 EBITDA margin 24.80% vs 21.3% (YoY) (Positive)
- May 20, 2026 09:09
Mindteck (India): Q4 Cons Net Profit Rs. 10.20 Cr vs 6.80 Cr (YoY), Q4 Revenue Rs. 104 Cr vs 104 Cr (YoY), Q4 EBITDA margin 10.26% vs 8.24% (YoY) (Positive)
- May 20, 2026 09:09
Orkla India: Q4 Cons Net Profit Rs. 73.40 Cr vs 35.20 Cr (YoY), Q4 Revenue Rs. 625 Cr vs 590 Cr (YoY), Q4 EBITDA margin 15.54% vs 16% (YoY) (Positive)
- May 20, 2026 09:09
Bhagiradha Chemicals: Q4 Cons Net Profit Rs. 4.07 Cr vs loss 90 Lakhs (YoY), Q4 Revenue Rs. 160 Cr vs 120 Cr (YoY) (Positive)
- May 20, 2026 09:09
Prince pipes: Q4 Net Profit Rs. 56.10 Cr vs 24.20 Cr (YoY), Q4 Revenue Rs. 850 Cr vs 720 Cr (YoY), Q4 EBITDA margin 12.89% vs 7.6% (YoY) (Positive)
- May 20, 2026 09:09
Fine Organic Industries: Q4 Net Profit Rs. 117 Cr vs 97.10 Cr (YoY), Q4 Revenue Rs. 625 Cr vs 590 Cr (YoY), Q4 EBITDA margin 20.76% vs 19.70% (YoY) (Positive)
- May 20, 2026 09:08
Shaily Engineering: Q4 Net Profit Rs 40.20 Cr vs 28.60 Cr (YoY), Q4 Revenue 237 Cr vs 220 Cr (YoY), Q4 EBITDA Margin 27.71% vs 25.02% (YoY) (Positive)
- May 20, 2026 09:08
Anthem Bio: Q4 Net Profit Rs 190 Cr vs 82.6 Cr (YoY), Q4 Revenue Rs 611 Cr vs 483 Cr (YoY) (Positive)
- May 20, 2026 09:08
Dredging Corp: Q4 Cons Net Profit Rs. 86.9 Cr vs loss 24.6 cr (YoY), Q4 Revenue Rs. 478 Cr vs 276 Cr (YoY) (Positive)
- May 20, 2026 09:07
BEL Q4 results live: Highlights
Bharat Electronics Limited reports its Q4 results
👉Net Profit At ₹2,203 Cr Vs CNBC-TV18 Poll Of ₹2,138 Cr
👉Revenue At ₹10,177 Cr Vs CNBC-TV18 Poll Of ₹10,012 Cr
👉EBITDA At ₹2,962 Cr Vs CNBC-TV18 Poll Of ₹2,775 Cr
👉Margin At 29.1% Vs CNBC-TV18 Poll Of 27.71%
- May 20, 2026 09:07
Q4 results live:
Researchbytes Analyst App
https://play.google.com/store/apps/details?id=com.intelegain.rb
Conference call Replay available in Various speeds!
Researchbytes Events Update
As of 08:54 AM Wednesday 20 May 2026
Can set alert for them at www.researchbytes.com
9:00 AM Automotive Axle
Dial: +91 22 6280 1222
Weblink: https://tinyurl.com/22fnjkjb
10:00 AM PG Electroplast
Dial: +91 22 6280 1366
Weblink: https://tinyurl.com/mpmtarku
11:00 AM Bluespring Enter
Dial: +91 22 6280 1259
Weblink: https://tinyurl.com/59645z4b
11:00 AM BPCL
Dial: +91 22 6280 1342
Weblink: https://tinyurl.com/d2kpp832
11:00 AM Anthem Biosciences
Dial: +91 22 6280 1366
Weblink: https://tinyurl.com/5x38nd8b
11:00 AM United Foodbrands
Dial: +91 22 6280 1467
Weblink: https://tinyurl.com/3cwsrcfj
11:00 AM Prince Pipes
Dial: +91 22 6280 1550
Weblink: https://tinyurl.com/4shx5akb
11:00 AM MAP MY INDIA
Dial: 022 6280 1384
Weblink: https://tinyurl.com/bddbdysh
11:00 AM
Dial: 086 3416 9108
Weblink: https://tinyurl.com/mwa8a8ea
12:00 PM MANKIND PHARMA
Weblink: https://tinyurl.com/vzf75dfj
12:00 PM Godawari Power
Dial: +91 22 6280 1455
Weblink: https://tinyurl.com/sxv832dj
12:00 PM ZIM Laboratory
Dial: 086 3416 8787
Weblink: https://tinyurl.com/2s4kwuwr
12:30 PM J Kumar Infra
(Results, Investor/Analyst Presentation, Press Release)
Dial: +91 22 6280 1545
Weblink: https://tinyurl.com/2zpb3ukn
1:30 PM Healthcare Global
Dial: +91 22 6280 1141
Weblink: https://tinyurl.com/38wk3ta9
2:00 PM Eureka Forbes
Dial: +91 22 6280 1334
Weblink: https://tinyurl.com/4cty2j6n
- May 20, 2026 09:03
Q4 results live: Key results to watch out for
Important Result Calendar
20-May-2026
derivatives
• Bosch Ltd
• Jubilant Foodworks Ltd
• Apollo Hospitals Enterprise Ltd
• Grasim Industries Ltd
• Samvardhana Motherson Intl Ltd
• Sammaan Capital Ltd
Cash Segment
• Medplus Health Services Ltd.
• Honeywell Automation India Ltd
• Eris Lifesciences Ltd
• Irb Infrastructure Developers
• Ola Electric Mobility Ltd
• Action Construction Equipment
• Embassy Developments Ltd
• International Gemmological Institute
• JK Lakshmi Cement Ltd
• Whirlpool Of India Ltd
21-May-2026
derivatives
• Page Industries Ltd
• ITC Ltd
• Aurobindo Pharma Ltd
• Fsn E-Commerce Ventures Ltd
• Gail (India) Ltd
• Life Insu Corp Of India
• Max Healthcare Institute Ltd
• Prestige Estates Projects Ltd
• Rail Vikas Nigam Ltd
Cash Segment
• Bikaji Foods International Ltd
• Emami Ltd
• Engineers India Ltd
• Dr. Agarwal’s Health Care Ltd
• Honasa Consumer Ltd
• Rashtriya Chems & Fertilizers
• Reliance Power Ltd
• Sun Tv Network Ltd
• Welspun Corp Ltd
Published on May 20, 2026